肝细胞腺瘤、肝细胞癌和肝内胆管癌的形态分子分类更新
本文综述肝细胞腺瘤(HCA)、肝细胞癌(HCC)和肝内胆管癌(iCCA)的形态分子分类及其影像表现。基于组织病理学与分子谱的形态分子分类可识别具有特征性影像表现和并发症的不同亚型,多期CT和多参数MRI在诊断、分期、疗效评估和监测中起重要作用。
要点
- HCA亚型包括HNF1A失活型、炎症型、β-catenin激活型、β-catenin激活炎症型和sonic hedgehog型,各具特征性影像表现和并发症。
- HCC分为增殖型和非增殖型,增殖型包括巨梁状-肿块型、TP53突变型、硬化型、透明细胞型、纤维板层型、肉瘤样HCC及混合性HCC-胆管癌。
- iCCA按胆管累及水平分为小胆管型和大胆管型,两型在发病机制、分子特征、影像表现和生物学行为上存在显著差异。
核心结论
- 肝肿瘤的形态分子分类将组织病理学与分子谱结合,可识别具有特征性影像表现和并发症的亚型;特定影像表型可与遗传异常相关,识别替代影像标志物可能有助于避免基因检测。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告;本文目的为综述特定形态分子亚型HCA、HCC和iCCA的影像表现并讨论治疗和预后意义。
关键影像表现/征象
- HCA不同亚型具有特征性影像表现和并发症,包括HNF1A失活型、炎症型、β-catenin激活型、β-catenin激活炎症型和sonic hedgehog型。
- HCC可分为增殖型和非增殖型,增殖型包括巨梁状-肿块型、TP53突变型、硬化型、透明细胞型、纤维板层型、肉瘤样HCC及混合性HCC-胆管癌,非增殖型包括脂肪性肝炎型和β-catenin突变型。
- iCCA按胆管累及水平分为小胆管型和大胆管型,两型在影像表现和生物学行为上存在显著差异。
诊断标准与关键数值
- HCA形态分子亚型包括HNF1A失活型、炎症型、β-catenin激活型、β-catenin激活炎症型和sonic hedgehog型。
- HCC分为增殖型(巨梁状-肿块型、TP53突变型、硬化型、透明细胞型、纤维板层型、肉瘤样HCC及混合性HCC-胆管癌)和非增殖型(脂肪性肝炎型和β-catenin突变型)。
- iCCA按胆管累及水平分为小胆管型和大胆管型。
临床应用与阅片要点
- 多期CT和多参数MRI在肝肿瘤的诊断、分期、疗效评估和监测中起重要作用。
- 特定影像表型可与遗传异常相关,识别替代影像标志物可能有助于避免基因检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatocellular adenomas (HCAs), hepatocellular carcinomas (HCCs), and intrahepatic cholangiocarcinomas (iCCAs) are a highly heterogeneous group of liver tumors with diverse pathomolecular features and prognoses. High-throughput gene sequencing techniques have allowed discovery of distinct genetic and molecular underpinnings of these tumors and identified distinct subtypes that demonstrate varied clinicobiologic behaviors, imaging findings, and complications. The combination of histopathologic findings and molecular profiling form the basis for the morphomolecular classification of liver tumors. Distinct HCA subtypes with characteristic imaging findings and complications include HNF1A-inactivated, inflammatory, β-catenin-activated, β-catenin-activated inflammatory, and sonic hedgehog HCAs. HCCs can be grouped into proliferative and nonproliferative subtypes. Proliferative HCCs include macrotrabecular-massive, TP53-mutated, scirrhous, clear cell, fibrolamellar, and sarcomatoid HCCs and combined HCC-cholangiocarcinoma. Steatohepatitic and β-catenin-mutated HCCs constitute the nonproliferative subtypes. iCCAs are classified as small-duct and large-duct types on the basis of the level of bile duct involvement, with significant differences in pathogenesis, molecular signatures, imaging findings, and biologic behaviors. Cross-sectional imaging modalities, including multiphase CT and multiparametric MRI, play an essential role in diagnosis, staging, treatment response assessment, and surveillance. Select imaging phenotypes can be correlated with genetic abnormalities, and identification of surrogate imaging markers may help avoid genetic testing. Improved understanding of morphomolecular features of liver tumors has opened new areas of research in the targeted therapeutics and management guidelines. The purpose of this article is to review imaging findings of select morphomolecular subtypes of HCAs, HCCs, and iCCAs and discuss therapeutic and prognostic implications. Online supplemental material is available for this article. ©RSNA, 2022.
引用
- Katabathina VS, Khanna L, Surabhi VR, et al. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma. Radiographics. 2022. PMID: 35776676. doi:10.1148/rg.210206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。